Zio XT ECG Monitoring System vs PMcardio

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 75/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by iRhythm Technologies
VS
by Powerful Medical

AI Verdict

These two tools are adjacent competitors, both leveraging AI for ECG interpretation in cardiology. Zio XT focuses on long-term, continuous cardiac monitoring via a wearable biosensor for arrhythmia detection, while PMcardio provides instant, point-of-care ECG interpretations for a broader range of over 50 cardiac conditions, including STEMI and reduced LVEF, across mobile and web platforms.

Choose Zio XT ECG Monitoring System if…

Choose Zio XT if you need extended, continuous cardiac monitoring for up to 14 days to detect infrequent or paroxysmal arrhythmias that might be missed by shorter monitoring periods. Its wearable, water-resistant design and lack of external wires promote high patient compliance and comfort during normal daily activities, making it suitable for patients who need discreet, long-term monitoring. This tool is also beneficial for reducing retesting rates and achieving a faster time to clinical diagnosis compared to other ambulatory cardiac monitors.

View Zio XT ECG Monitoring System →

Choose PMcardio if…

Choose PMcardio if you require rapid, AI-powered interpretation of 12-lead ECGs at the point of care for immediate assessment of over 50 cardiac conditions, including critical STEMI/OMI detection. This tool is ideal for emergency settings, primary care, or any situation where quick, expert-level ECG analysis is crucial for confident decision-making and optimizing patient triage and care pathways.

View PMcardio →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Zio XT ECG Monitoring System PMcardio
Pricing Contact for pricing Freemium
Deployment Cloud-based (AWS EC2 platform), no on-premise hardware required. Mobile app (iOS and Android), Web platform, Enterprise integrations with EHR/CVIS and EMS systems
BAA Available Yes AI-estimated Unknown
FDA Status Yes AI-estimated Pending AI-estimated
HIPAA Yes AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Zio XT ECG Monitoring System

Zio XT offers a wearable, wire-free biosensor that patients can wear for up to 14 days, including during daily activities like showering, promoting high patient compliance and comfort. PMcardio, while accessible via mobile and web, requires users to actively scan ECGs, which may introduce more steps and potential for user error compared to the passive, continuous monitoring of Zio XT.

Clinical Value

PMcardio

PMcardio boasts a broader diagnostic capability, detecting over 50 cardiac conditions and offering AI explainability with heatmaps, which can enhance clinician understanding and trust. It has also demonstrated superior accuracy in detecting acute myocardial infarction and reducing false STEMI alarms in multiple studies. While Zio XT provides high diagnostic yield for arrhythmias over extended monitoring periods, its diagnostic scope is more focused on arrhythmia detection rather than a wide range of cardiac conditions.

Pricing & Value

PMcardio

PMcardio offers a freemium model with 5 free ECG analyses per month, allowing individual clinicians to try the service before committing to a paid plan. Its transparent pricing for individual and team plans is readily available. Zio XT's pricing is primarily enterprise-focused and requires direct contact for details, with Medicare rates suggesting a higher per-patient cost.

Enterprise Readiness

PMcardio

PMcardio is designed for enterprise deployment, offering integrations with EHR/CVIS and EMS systems, and a unified platform for system-wide cardiac care coordination. It emphasizes a single integration and security review for health systems. Zio XT is cloud-based and HIPAA compliant, but its enterprise integration capabilities are not as explicitly detailed or as broad as PMcardio's.

Innovation

PMcardio

PMcardio demonstrates strong innovation with its AI explainability feature (ECGxplainu2122) that provides visual heatmaps for diagnostic rationale, and its focus on detecting a wide array of cardiac conditions, including subtle STEMI equivalents and reduced LVEF. Zio XT's innovation lies in its extended wear time and high patient compliance for continuous arrhythmia monitoring, but its core technology is a more established form of wearable ECG.

Support & Docs

Tie

Both tools provide essential documentation. Zio XT offers clinical reference manuals and instructions for use for its devices and software. PMcardio provides a help center with instructions for use for individuals and regulatory documentation. Without further specific details on the breadth and responsiveness of their support channels (e.g., 24/7 support, dedicated account managers), it's difficult to definitively pick a winner.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Zio XT ECG Monitoring System PMcardio
Company iRhythm Technologies Powerful Medical
Tagline Innovating the Future of Cardiac Monitoring: Precision Brought to Your Practice AI that reads ECGs in seconds
Categories Cardiology AI, Wearables & Remote Monitoring (RPM) Cardiology AI, Clinical Decision Support & Reference
Key Feature 1 Wearable single-lead ECG biosensor (Zio biosensor) Instant AI-powered ECG interpretations
Key Feature 2 Continuous ambulatory cardiac monitoring for up to 14 days Detection of 50+ ECG findings (including STEMI/OMI, rhythms, reduced LVEF, conduction disorders)
Key Feature 3 Water-resistant design for normal daily activities, including showering Queen of Heartsu2122 - STEMI and OMI Detection
Key Feature 4 Proprietary, FDA-cleared deep-learned AI algorithm for ECG data analysis ECGxplainu2122 - Visual AI Explainability with heatmaps

Videos

Demos, reviews, and walkthroughs featuring Zio XT ECG Monitoring System and PMcardio.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Zio XT is a wearable biosensor for continuous ambulatory cardiac monitoring for up to 14 days, with data analyzed by AI and cardiac physiologists, and a report sent to the physician. PMcardio offers instant AI-powered ECG interpretations via a mobile app, web platform, and EHR integrations, designed for rapid assessment at the point of care for over 50 cardiac conditions.
Zio XT offers EHR integration to simplify data collection and entry, enhance interdisciplinary access, and boost workflow efficiency. PMcardio provides enterprise integrations with EHR/CVIS and EMS systems, allowing for seamless data ingestion and export of reports to the EHR, and is built for multi-pathway, multi-site cardiac care delivery.
Zio XT has demonstrated high diagnostic yield for arrhythmias, with studies showing it can detect 81% more arrhythmias compared to 24-hour Holter monitoring and is associated with the highest diagnostic yield and fastest time to diagnosis compared to other ambulatory cardiac monitors. PMcardio's AI ECG interpretation has been clinically validated to outperform standard-of-care methods, offering 2x sensitivity for early STEMI detection and identifying atrial fibrillation with 98.3% accuracy.
Zio XT is suitable for Cardiology, Emergency Medicine, and Internal Medicine, particularly for continuous ambulatory monitoring up to 14 days for arrhythmia detection. PMcardio is also applicable across Cardiology, Emergency Medicine, and Internal Medicine, providing instant AI-powered ECG interpretations for over 50 cardiac conditions, including acute events like STEMI and OMI, and screening for structural heart disease.
PMcardio for Organizations offers audit logs as part of its enterprise plan, providing visibility into performance, variation, and outcomes across deployed suites, which can be used for QA workflows and protocol improvement.
PMcardio for Organizations is designed as a unified cardiac AI platform to support the full cardiac care journey across multiple sites and pathways, enabling standardization of clinical decisions and tracking performance across all deployed suites. Zio XT's cloud-based platform and EHR integration can also facilitate data access and workflow efficiency across different sites.

Backers

Who funded each tool's parent company.

PMcardio

AI Tool Finder
AI-powered search. Results may not be comprehensive.